Reaction
Infusion Site Haematoma reporting signals
As of the last recalculation, Infusion Site Haematoma appears in 457 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is NATALIZUMAB (PRR 48.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Natalizumab | 137 | 48.6 | 48.6 |
| Treprostinil | 56 | 23.0 | 23.0 |